Abstract
The heparan sulphate proteoglycan (HSPG) of the glomerular basement membrane (GBM) is considered to be mainly responsible for the charge selectivity of the GBM; decreased HSPG results in a decreased anionic charge of the GBM with increased heparan sulphate (HS) in the urine and is believed to be responsible for the proteinuria of the congenital nephrotic syndromes (CNS). Urinary HS and chondroitin sulphate (CS) concentrations in children with CNS of the Finnish type (CNF) and the total glycosaminoglycans (GAG) in amniotic fluid of CNF pregnancies were measured by three methods: Alcian blue, Safranine O and uronic acid assays. The total urinary GAG in CNF and other nephrotic patients was comparable to controls with all three methods. Urinary CS and HS in CNF did not differ significantly from controls. Total amniotic fluid GAG was also similar in CNF and control pregnancies. These results suggest some pathogenetic mechanism other than loss of glomerular HS chains in urine for the proteinuria of CNF.
Similar content being viewed by others
References
Hallman N, Hjelt L (1959) Congenital nephrotic syndrome. J Pediatr 55: 152–162
Norio R (1966) Heredity in the congenital nephrotic syndrome of the Finnish type. Ann Paediatr Fenn [Suppl 12]: 27: 1–94
Seppälä M, Rapola J, Huttunen NP, Aula P, Karjalainen O, Ruoslahti E (1976) Congenital nephrotic syndrome: prenatal diagnosis and genetic counseling by estimation of amniotic fluid and maternal serum alphafetoprotein. Lancet I: 123–125
Mahan JD, Mauer SM, Sibley RK, Vernier RL (1984) Congenital nephrotic syndrome: evolution of medical management and results of renal transplantation. J Pediatr 105: 549–557
Holmberg C, Jalanko H, Koskimies O, Leijala M, Salmela K, Eklund B, Ahonen J (1990) Renal transplantation in children with congenital nephrotic syndrome of the Finnish type. Transplant Proc 22: 158
Huttunen NP, Rapola J, Vilska J, Hallman N (1980) Renal pathology in congenital nephrotic syndrome of Finnish type: a quantitative light microscopic study on 50 patients. Int J Pediatr Nephrol 1: 10–16
Rapola J, Sariola H, Ekblom P (1984) Pathology of fetal congenital nephrosis: immunohistochemical and ultrastructural studies. Kidney Int 25: 701–707
Autio-Harmainen H, Karttunen T, Risteli L, Risteli J, Rapola J (1985) Accumulation of laminin and type IV collagen in the kidney in congenital nephrosis. Kidney Int 27: 662–666
Autio-Harmainen H, Rapola J (1983) The thickness of the glomerular basement membrane in congenital nephrotic syndrome of the Finnish type. Nephron 34: 48–50
Rapola J, Huttunen NP, Hallman N (1992) Congenital and infantile nephrotic syndrome. In: Edelmann C (ed) Pediatric kidney disease, 2nd edn. Little Brown, Boston, p 1291
Autio-Harmainen H, Rapola J (1982) Renal pathology of fetuses with congenital nephrotic syndrome of the Finnish type. A qualitative and quantitative light microscopic study. Nephron 29: 158–163
Vernier RL, Klein DJ, Sisson SP, Mahan JD, Oegema TR, Brown DM (1983) Heparan sulfate-rich anionic sites in the human glomerular basement membrane. Decreased concentration in congenital nephrotic syndrome. N Engl J Med 309: 1001–1009
Mahan JD, Sisson-Ross SS, Vernier RL (1989) Anionic sites in the human kidney: ex vivo perfusion studies. Mod Pathol 2: 117–124
Vermylen C, Levin M, Mossman J, Barratt TM (1989) Glomerular and urinary heparan sulphate in congenital nephrotic syndrome. Pediatr Nephrol 3: 122–129
Jadresic LP, Filler G, Barratt TM (1991) Urine glycosaminoglycans in congenital and acquired nephrotic syndrome. Kidney Int 40: 280–284
Heuvel LPWJ van den, Born J van den, Jalanko H, Schröder CH, Veerkamp JH, Assmann KJM, Berden JHM, Holmberg C, Rapola J, Monnens LAH (1992) The glycosaminoglycan content of renal basement membranes in the congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol 6: 10–15
Rapola J (1987) Congenital nephrotic syndrome. Pediatr Nephrol 1: 441–446
Whiteman P (1973) The quantitative determination of glycosaminoglycans in urine with Alcian blue 8GX. Biochem J 131: 351–357
Galambos JT (1967) Effect of borate and sulfamate on the carbazole color of sugars. Anal Biochem 19: 119–132
Lammi M, Tammi M (1988) Densitometric assay of nanogram quantities of proteoglycans precipitated on nitrocellulose membrane with Safranin O. Anal Biochem 168: 352–357
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254
Michelacci YM, Glashan RQ, Schor N (1989) Urinary excretion of glycosaminoglycans in normal and stone forming subjects. Kidney Int 36: 1022–1028
Gambaro G, Cicerello E, Mastrosimone S, Lavagnini T, Baggio B (1989) High urinary excretion of glycosaminoglycans: a possible marker of glomerular involvement in diabetes. Metabolism 38: 419–420
Hotz P, Pilliod J, Boillat MA (1989) Glycosaminoglycans and urine flow rate. Nephron 51: 271–273
Bower L, Warren C, Manley G (1992) Human serum and urine glycosaminoglycans in health and in patients with chronic renal failure. Ann Clin Biochem 29: 190–195
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ljungberg, P. Glycosaminoglycans in urine and amniotic fluid in congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol 8, 531–536 (1994). https://doi.org/10.1007/BF00858117
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00858117